Physician profile
Robert B Turnage
NPI 1073611703
$2,643.28
in general payments reported to CMS, 2019-2025
18 companies · $601 in 2025
The $601 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $252 · 2021: $221 · 2022: $741 · 2023: $399 · 2024: $158 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,271.49 | 2021-2025 | Valiant Captivia, Endurant Iis, Corevalve Evolut R |
| Medtronic Vascular, INC. | $396.16 | 2019-2020 | |
| Abiomed | $269.57 | 2022 | |
| Edwards Lifesciences Corporation | $131.18 | 2023-2025 | Pascal, Inspiris Resilia Aortic Valve |
| Getinge USA Sales, LLC | $110.12 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Abbott Laboratories | $105.00 | 2022 | |
| Atricure, INC. | $86.37 | 2022-2025 | Synergy Ablation System |
| Lsi Solutions INC | $54.25 | 2022-2023 | Cor Knot |
| Gilead Sciences, INC. | $35.61 | 2019 | |
| Cvrx, INC. | $34.23 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $24.22 | 2021-2022 | |
| Lundbeck LLC | $22.78 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.40 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.01 | 2019 | |
| Artivion, INC. | $17.25 | 2025 | Amds-Ascyrus Medical |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.96 | 2019 | |
| Lemaitre Vascular, INC. | $16.36 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Turnage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.